# Liquid Valine and Isoleucine in Maple Syrup Urine Disease

> **NCT06581991** · NA · NOT_YET_RECRUITING · sponsor: **Meta Healthcare Ltd** · enrollment: 5 (estimated)

## Conditions studied

- Maple Syrup Urine Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Valine oral solution (50mg/ml) and isoleucine oral solution (25mg/ml)

## Key facts

- **NCT ID:** NCT06581991
- **Lead sponsor:** Meta Healthcare Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2024-09-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06581991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06581991, "Liquid Valine and Isoleucine in Maple Syrup Urine Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06581991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*